I don’t think the issue is number of days but lack of p value in the overall trial and not enough critical patients for stat sig in the critical sub group? That’s why I believe we sent new protocol for 140 patients critical only. I hope the FDA agreed 140 would be enough.... It’s clear to me that the SOC has improved and probably will continue to do so. I hope we are not chasing our tail here because we have already wasted a year and untold dollars.
